#ABCT

This is what I've been waiting for. #AVCT #AVA6207

It's been my hope that a partnership will be announced with the warhead for AVA6207. Here's to hope! And still being able to buy at reasonable prices. #AVCT

@PJ_Crabb @Lord_Matti #AVCT If you mean why did we fall 41% from 9am 16th September @89p like a stone I don't think you need to look any further than Heights with their free pass to still short 12.8m shares at anything above 75p That free pass will be gone April latest imo

@Mike182035 @Lord_Matti @89p Nonsense, they didn’t do so before and of course it’s against their terms. They have forward sold ahead of conversion when obvious shares would be converted but not of late given cash payments. You’re talking more rubbish. #AVCT

That’s hot 🔥🌓 austin butler // callum turner #ABCT

At #ABCT, we are celebrating #BlackHistoryMonth  by highlighting the work of some our members. Today, we feature Dr. Ryan DeLapp (@DrDelappPhD).

Great discussion today at the @LongwoodLeaders forum in Boston on prioritizing the pipeline. Delighted to discuss the #AVCT pipeline & how we make hard decisions: sure bets v. Moonshots and those between. Big pharma and biotech have similar priority: patient impact #LetsDoThis

Our CEO Christina Coughlin participating in the Prioritizing the Pipeline panel with @LongwoodLeaders in Boston today, discussing how we assess our platform opportunities to deliver high patient impact. #AVCT

Nice to meet you👋🫣🌓 austin butler // callum turner #ABCT

AVA6103 added to the US National Cancer Institute's NCI Thesaurus on 26 October 2026, receiving its own standardised biomedical terminology entry (C229108). #AVCT

LOL @JohnLewisRetail Christmas advert -- forget those ungrateful grandkids, buy YOURSELF a real XMAS gift at bargain prices -- @avacta #AVCT shares at 57p each. A gift guaranteed to keep on giving.

Are you looking to present your work at #ABCT this year?👀 We are looking for researchers who would like to collaborate as individual presenters on a symposium related to digital mental health interventions. DM me if interested!

CEO Christina Coughlin and CFO Brian Hahn will be at @Jefferies Healthcare Conference, Nov 16-19 in London. Curious how pre|CISION® keeps potent payloads silent in the bloodstream and active in the tumor? Book a 1:1 via the partnering system. #AVCT

Denim on denim 👀💙🌗 austin butler // callum turner #ABCT

Wouldn’t it be great to know how #AVCT actually ends? So many possibilities.

Keep it coming 😉🍽️ 🌗 austin butler // callum turner #ABCT

What happens if AVA6103 is stabilising disease in heavily pretreated and drug resistant patients, whilst running this clean safety profile? I’ll immediately bank AVA6103 as a ‘safe bet’ and imagine the ‘moon shoot’ possibilities #AVCT pre|CISION platform technology can achieve.

Your first sentence ⬆️ Isn’t it broadly acknowledged that this is already occurring in the #AVCT 6103 P1 trial, consistently and across all the indications? Patients from the early cohorts would not still be on drug, were they not experiencing benefit (i.e. disease control). The fact that so many are still being dosed suggests the DCR could be absolutely knockout at the higher dosing levels (not to mention that we’ll start seeing tumours being decimated at these higher dosing levels). @avacta has essentially told the market that 6103 is already working - directly, with regards to PK; but implicitly, with regards to efficacy. I myself certainly already assume 6103 to be a safe bet (and with a reasonable probability of it becoming a multi-multi-billion-$ drug). So yes… first Moonshot is 6207! Week after next should be a real eye opener.

Join @PatriciaResick and me at our workshop at @ABCTNOW to sharpen your CPT skills. Registration is now open! #abct #abct2022 #cbtworks

@tom_the_bomb__ In the hands of a BP with very deep pockets Tom #AVCT

Avacta will present AVA6207, its Next-Generation pre|CISION® dual payload peptide-drug conjugate, in a poster at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, taking place in Barcelona, Spain, from November 18-20. #AVCT

Let’s have a talk, son 🏠🌗✨ austin butler // callum turner // harris dickinson #ABCT

😍😍😍! My first abstract was presented in 2019 at ABCT in Atlanta by my colleague, as I did not have a U.S. visa at the time. This year at #ABCT, I was thrilled to present my first poster in person and meet wonderful colleagues and friends! @ABCTNOW

#AVCT Lots of hints here about the real story which is shareholder valve is a little more downstream. The everlasting wait for the SP re-rate is likely to continue for a few months longer at least. The journey to huge shareholders rewards possibly requires continued short term pain. Francis speaks the truth unlike the lies and deceit spewed from the insider trading TVR5 gas chamber.